| CAS ID: | 394730-60-0 |
| Molecular Formula: | C27H45N5O5 |
| Molecular Weight: | 519.7 g/mol |
| Monoisotopic Mass: | 519.3421 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | VICTRELIS | SCH 503034 | BOCEPREVIR |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1 | See All |
| InChI Key: | LHHCSNFAOIFYRV-DOVBMPENSA-N | |
| Smiles: | CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(=O)N)C2(C)C)C(C)(C)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01463956 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | November 2, 2011 | Last Verified | January 24, 2017 |
| Sponsor | French National Agency for Research on AIDS and Viral Hepatitis | ||
| PubChem: | 10324367 |
| ChEMBL: | CHEMBL218394 |